Variables
|
High Gal3BP (mg/l) (≥3.3 mg/l, ≥80th percentile)
|
---|
All patients (n = 285)
|
Women (n = 124)
|
Men (n = 161)
|
---|
No
|
Yes
|
p valuea
|
No
|
Yes
|
p valuea
|
No
|
Yes
|
p value a
|
---|
N
|
226 (79)
|
59 (21)
| |
87 (70)
|
37 (30)
| |
139 (86)
|
22 (14)
| |
Gender
|
Women
|
87 (39)
|
37 (63)
|
0.001 b
|
–
|
–
|
–
|
–
|
–
|
–
|
Men
|
139 (62)
|
22 (37)
|
–
|
–
|
–
|
–
|
–
|
–
|
Age
|
42 (32, 51)
|
41 (29, 50)
|
0.49
|
42 (31, 51)
|
40 (30, 48)
|
0.63
|
43 (32, 51)
|
46 25, 55)
|
0.98
|
Diabetes duration
|
21 (11, 31)
|
18 (11, 27)
|
0.093
|
19 (10, 29)
|
19 (13, 28)
|
> 0.99
|
21 (13, 33)
|
16 (6, 26)
|
0.032
|
sCD163 (mg/l)
|
0.4 (0.3, 0.5)
|
0.5 (0.3, 0.6)
|
0.088
|
0.4 (0.3, 0.5)
|
0.5 (0.3, 0.6)
|
0.15
|
0.4 (0.3. 0.5)
|
0.5 (0.3–0.6)
|
0.26
|
Galectin-3 (μg/l)
|
0.9 (0.6, 1.6)
|
1.2 (0.7, 2.1)
|
0.056
|
0.8 (0.5, 1.4)
|
1.1 (0.5, 1.7)
|
0.24
|
0.9 (0.6, 1.9)
|
1.7 (0.8, 2.6)
|
0.035
|
HbA1c
|
mmol/mol
|
61 (54, 69)
|
68 (58, 79)
|
0.004
|
63 (53, 71)
|
71 (59, 82)
|
0.013
|
61 (54, 68)
|
65 (55, 76)
|
0.20
|
%
|
7.8 (7.1–8.4)
|
8.4 (7.5–9.4)
|
7.9 (7.0, 8.6)
|
8.6 (7.5, 9.6)
|
7.8 (7.1, 8.4)
|
8.1 (7.2, 9.1)
|
TC (mmol/l)
|
4.5 (4.1, 5.1)
|
4.7 (4.1, 5.3)
|
0.20
|
4.6 (4.1, 5.3)
|
4.7 (4.9, 5.4)
|
0.90
|
4.4 (4.0, 5.0)
|
4.8 (4.2, 5.1)
|
0.14
|
Triglycerides (mmol/l)
|
0.9 (0.6, 1.1)
|
1.0 (0.8, 1.6)
|
0.001
|
0.8 (0.6, 1.1)
|
1.0 (0.7, 1.5)
|
0.065
|
0.9 (0.7, 1.2)
|
1.2 (1.0, 1.8)
|
< 0.001
|
LDL-cholesterol (mmol/l)
|
2.8 (2.4, 3.2)
|
3.0 (2.4, 3.6)
|
0.12
|
2.8 (2.4, 3.3)
|
2.9 (2.2, 3.6)
|
0.82
|
2.8 (2.4, 3.2)
|
3.2 (2.6, 3.6)
|
0.036
|
HDL-cholesterol (mmol/l)
|
1.5 (1.3, 1.8)
|
1.4 (1.1, 1.7)
|
0.053
|
1.6 (1.4, 1.9)
|
1.5 (1.2, 1.8)
|
0.17
|
1.5 (1.2, 1.8)
|
1.3 (1.1, 1.5)
|
0.024
|
Creatine (μmol/l)
|
70 (63–80)
|
66 (53–76)
|
0.005
|
64 (56, 70)
|
61 (52, 69)
|
0.17
|
74 (68, 82)
|
72 (66, 80)
|
0.30
|
Abdominal obesity
|
37 (16)
|
10 (18)
|
0.84 b
|
25 (29)
|
9 (26)
|
> 0.99 b
|
12 (9)
|
1 (5)
|
> 0.99 b
|
General obesity
|
20 (9)
|
14 (25)
|
0.002 b
|
14 (16)
|
8 (23)
|
0.44 b
|
6 (4)
|
6 (27)
|
0.002 b
|
Systolic BP (mmHg)
|
120 (115, 130)
|
120 (110, 130)
|
0.37
|
120 (110, 130)
|
115 (110, 130)
|
0.57
|
125 (120, 130)
|
128 (110, 136)
|
0.69
|
Diastolic BP (mmHg)
|
70 (70,76)
|
70 (65, 75)
|
0.48
|
70 (65, 75)
|
70 (62, 70)
|
0.27
|
70 (70, 80)
|
75 (70, 80)
|
0.19
|
Smoking
|
21 (10)
|
6 (11)
|
0.80 b
|
14 (16)
|
8 (23)
|
0.44 b
|
14 (10)
|
3 (15)
|
0.47 b
|
Physical inactivity
|
19 (9)
|
10 (18)
|
0.085 b
|
6 (7)
|
6 (18)
|
0.18 b
|
13 (10)
|
4 (19)
|
0.26 b
|
Depression
|
21 (9)
|
9 (15)
|
0.23 b
|
8 (9)
|
6 (16)
|
0.35 b
|
8 (9)
|
6 (16)
|
0.35 b
|
Cardiovascular complications
|
6 (3)
|
4 (7)
|
0.22 b
|
1 (1)
|
3 (8)
|
0.079 b
|
5 (4)
|
1 (4)
|
0.59 b
|
Diabetes retinopathy
|
162 (72)
|
43 (73)
|
> 0.99 b
|
58 (67)
|
30 (81)
|
0.14 b
|
104 (75)
|
13 (59)
|
0.12 b
|
Foot complications
|
36 (16)
|
11 (20)
|
0.55 b
|
7 (8)
|
6 (18)
|
0.19 b
|
29 (22)
|
5 (23)
|
> 099 b
|
Antidepressants
|
16 (7)
|
7 (12)
|
0.28 b
|
5 (6)
|
7 (19)
|
0.041 b
|
11 (8)
|
0
|
0.36 b
|
Antihypertensive drugs
|
77 (34)
|
19 (32)
|
0.88 b
|
22 (25)
|
13 (35)
|
0.28 b
|
55 (40)
|
6 (27)
|
0.35 b
|
Lipid lowering drugs
|
103 (46)
|
30 (51)
|
0.56 b
|
36 (41)
|
19 (51)
|
0.33 b
|
67 (48)
|
11 (50)
|
> 0.99 b
|
- a Mann-Whitney U test unless otherwise indicated. b Fisher’s Exact test
- Abdominal obesity: women p >0.99b, men p >0.99b
- General obesity: women p=0.44b, men= 0.002b